99.60
+2.50
+(2.57%)
At close: January 31 at 12:29:15 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in DKK | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 7 | 2 | 12 | 12 |
| Avg. Estimate | 27.96M | 152.8M | 347.42M | 2B |
| Low Estimate | -- | 11.5M | -- | 8.8M |
| High Estimate | 61M | 294.1M | 1.8B | 9.97B |
| Year Ago Sales | 23.23M | 15.09M | 342.79M | 347.42M |
| Sales Growth (year/est) | 20.36% | 912.66% | 1.35% | 477.07% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 22Z.F | -- | -- | -- | -- |
| S&P 500 | 9.91% | 10.33% | 14.01% | 13.75% |
Related Tickers
1AE.SG argenx SE
637.80
+1.75%
ARGX.VI argenx SE
642.80
+1.61%
CVALF Covalon Technologies Ltd.
2.0600
-4.19%
ORMP Oramed Pharmaceuticals Inc.
2.2400
+1.82%
ARGX argenx SE
655.13
-1.58%
UTHR United Therapeutics Corporation
351.17
-0.32%
CORT Corcept Therapeutics Incorporated
66.92
-4.26%
RNAZ TransCode Therapeutics, Inc.
7.56
-6.09%
NVAX Novavax, Inc.
8.69
-3.55%
RXRX Recursion Pharmaceuticals, Inc.
7.24
-5.85%